Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-12

Clinical Trial Update: EX-PRESS® P-50 and EX-PRESS® P-200

View source ↗

Summary

Results from completed clinical trials evaluating the EX-PRESS P-50 and EX-PRESS P-200 glaucoma devices have been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EX-PRESS P-200
  • EX-PRESS P-50

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma | Status: COMPLETED